ClearLine MD Celebrates Family Advocacy Day 26 June, 2018 ClearLine MD Celebrates Family Advocacy Day June 26-27 is Family Advocacy Day, when patients and families will travel to Washington D.C. to tell Congress why we must prioritize children’s health. Read More >
Infusion Pumps Inability to Effectively Deal with Air-in-Line Alarms 12 July, 2018 Infusion Pumps Inability to Effectively Deal with Air-in-Line Alarms Infusion systems have undergone significant technological developments over the past decade. However they have struggled to deal with air-in-line issues, indicative in growing “Alarm Fatigue”(1)(3), over 70 FDA recalls of infusion pumps (2007-2017) due to air-in-line issues (2) and a rising number of deaths and injuries due to air-in-line issues as reported to the FDA in relation to infusion pump devices (6). Read More >
Safe Infusion Practices 20 June, 2018 Safe Infusion Practices Intravenous (IV) infusion systems pose the greatest risk of medical error in magnet hospital systems.(1) To prevent IV-related medical errors, hospitals have implemented practices and protocols to protect patients from the dangerous risk of infections, needlesticks and infiltrations. One area that has been overlooked, however, are protocols and systems for avoiding dangerous air intrusion. Read More >
Electronic infusion devices were first introduced in the late 1960’s. At that time, the only available safety product to potentially prevent air from being infused was a 0.2 micron particulate filter. Read More >
Neonates are a high risk population for air embolisms, in particular cardiac air embolism. Although the clinical presentations of this event may vary, typical symptoms present as pallor, cyanosis, poor perfusion, bradycardia, and desaturation episodes which do not respond to positive pressure ventilation at 100%. Read More >
Air embolisms have been thought to be the result of in hospital accidents. While this is true in many cases there is new research showing that there are also certain common medical interventions which cause an increased risk of air embolism. Read More >
But Air Burden is something altogether more common and more insidious. There are innumerable times that air enters a patient’s venous system through their IVs but it is not recorded, simply because the patient did not have bad enough side effects or those side effects such as shortness of breath, chest pain, memory loss, lightheadedness, and decreased level consciousness were attributed to something else. Read More >
March 20, 2018 marks National Doctors’ Day and ClearLine MD would like to say thank you to all of the doctors around the world who work tirelessly to save lives and improve the lives of patients. Read More >
New PSMF Challenge to Eliminate in Hospital Air Embolism 26 March, 2018 New PSMF Challenge to Eliminate in Hospital Air Embolism The Patient Movement Association recently issued a new challenge as part of its Actionable Solutions program: Challenge 12B Air Embolism with the goal of truly making Air Embolisms a “never (happen) event.” Read More >
ClearLine MD celebrates Patient Safety Awareness week, March 12-18. Thank you to all the physicians, nurses, clinicians, patient safety officers, risk managers and administrative leaders who work tirelessly to protect patients from preventable harm. Thank you to all the patients who advocate for safety as well as healing. Read More >
Medical errors have grown to become the third leading cause of death in the United States topping 200,000 in 2016, per a report by BMJ. In BMJ analysis, death from medical error is defined as dying “from the care received rather than from the disease or injury that brings them to care.” Read More >
It is well known that air can enter a patient’s intravenous lines through multiple routes. But is permanent injury to a patient or mortality really the quality bar to which the medical community should hold itself to?
Read More >
Fluid warming is well known to create outgassing in liquids used for intravenous (IV) infusions. We recently conducted a study to quantify the amount of outgassing that would occur when two liters of blood are run through a fluid warming device. We found that a potentially clinically significant amount of outgassing occurs during the warming of two liters of blood. The ClearLine IV as an active air removal device substantially reduces the Air Burden that results from outgassing of warmed fluids. Read More >
As reported in the WSJ, the shortage of IV bags has shown no sign of improving. Hospitals are increasingly reporting that they are having to take specific measures to adjust including using other methods to administer medications and even postponing or delaying elective procedures because of a lack of supplies. Read More >
ClearLine MD has been awarded an Annual Patient Safety Innovation Award by the Patient Safety Movement for an important new technology in the ongoing fight to improve patient safety and eliminate preventable harm. ClearLine MD will receive its award at the upcoming 6th Annual World patient Safety, Science & Technology Summit on February 23rd, 2018. Read More >
The issues with “alarm fatigue” with Infusion pumps and its connection to Air-In-Line problems is well documented but not well addressed. One study of infusion pump alarms and alerts collected over a three-month period from 730 hospitals and including an analysis of 39,000,000 alarms showed that Air-in-Line alarms are second only to occlusion alarms for incident rates and accounted for 40% of all alarms. The study estimated up to 50 IV pump alarms or alerts per average patient day! Read More >
Infusion pumps have many benefits - precisely controlling flow rate first among them. But there are many challenges as well - the presence and detection of dangerous Air masses in line arguably first among them. Read More >
A serious shortage of the bags used to inject drugs intravenously is now evident after Hurricane Maria in September slammed into Puerto Rico and shut down production at three plants owned by Baxter International, which makes a large percentage of the IV bags used in the United States.
In many areas across the country, hospitals are watching their supplies of IV bags and in some cases, making some changes. Many affected by the shortage are administering some drugs by IV push, or in a syringe, instead of via an IV bag. Read More >
To illustrate and raise awareness of the significant amount of inadvertent Air Burden introduced to patients through IV fluid lines, ClearLine MD hosted a challenge during this year’s ASA. Using a setup that included… Read More >
ClearLine MD is excited to exhibit the ClearLine IV at the upcoming National Association of Neonatal Nurses meeting at the Providence Convention Center, October 11-13. Stop by booth #705 to see the ClearLine IV - the only FDA cleared device that automatically detects and removes air from IV lines. Read More >
Air in a patient’s vasculature is not a random event. Air Burden is directly caused by medical interventions and its presence correlates closely to specific events (syringe administration, warming of fluids, administration of blood). It often presents in clusters in narrow spans of time.
To test this, we recently completed studies at two leading Academic medical centers. Read More >
It is well known that air can enter a patient’s intravenous lines through multiple routes. Clinical observation and studies both have shown that use of fluid warmers, syringe administration of medication, IV bag changes and use of multi-port stopcocks are all sources of air.
That air is present in fluid lines and is delivered to patients is not debated. What is often debated is “how much is too much.” To date that debate has often centered on the amount of air required to cause mortality or significant morbidity - cardiac collapse, stroke, tachycardia, respiratory failure. Read More >
The Journal of Critical Care recently published an excellent article entitled, Vascular Air Embolism: A Silent Hazard to Patient Safety. This article provides a comprehensive review of published information on the prevention, detection and treatment of vascular air embolism. It highlights that although VAE is well-documented, it is a severely underappreciated medical condition. Few are aware of the serious clinical complications of VAE and the high risk for morbidity from VAE. Read More >
A new study by ClearLineMD explores the limitations and failure points of commonly used in-line IV filters. The results are alarming. Clinical concerns include restrictions in flow rates, bolusing and back-siphoning effects. Read More >
Boston Children’s Hospital has been ranked the number one pediatric hospital in the nation by U.S. News & World Report’s 2017-18 Best Children’s Hospitals, for the 4th year in a row. Boston Children’s Hospital ranked in the top three in all 10 pediatric specialties.
ClearLine MD is proud to supply the ClearLine IV device in support of BCH’s mission of providing the highest quality care. Congratulations, Boston Children’s Hospital on a well deserved ranking and thank you for your unparalleled service to children.
ClearLine IV is the only FDA cleared and CE certified device that automatically detects and removes air from IV lines. Using state of the art, ultrasound sensing technology, ClearLine IV detects and removes air masses as small as 25 microliters and works with pumps, warmers, IV bag sets, IV solutions, blood and blood products. Read More >
Findings from a study on the effectiveness of the ClearLine IV™ device were recently presented at the International Anesthesia Research Society (IARS) annual meeting held in Washington, D.C. in May 2017. The study utilized TEE imaging and optical densitometry to measure the amount of air in a patient’s heart following bolus administration of warm crystalloid fluid. The study found the ClearLine IV™ device effectively reduces the amount of air bubbles when delivering a warm solution at a fast rate. The study concluded that the ClearLine IV™ device reduces the risk of harmful and potentially fatal air emboli and can protect patients with patent foramen ovale (30-35% of the population) from paradoxical embolization.Findings from the study will be published in the fall of 2017. Read More >
This week is National Nurses Week and National Hospital Week, and we at ClearLine MD applaud the hardworking, caring, and dedicated professionals on the front lines of patient care and patient safety.
Nurses are fundamental to health care and play a vital role in caring for patients through every step of the healthcare process; they go above and beyond their call of duty to ensure that every patient is cared for and receives the best treatment.
ClearLine MD gives gratitude to all hospital employees and clinicians, whom often face the most challenging of patient circumstances, and persevere giving their very best to achieve the best possible outcomes.
To all healthcare professionals, we salute you. Thank you for everything that you do. Read More >
FDA has assigned a Class 1 designation to a recall of CareFusion Alaris infusion pumps originally announced in January. This marks the 10th Class 1 recall of an Alaris device since 2010.
Infusion pumps have been one of the most recall-plagued medical devices in the past decade. From 2005 through 2009, FDA reviewed roughly 56,000 reports of adverse events linked to infusion pumps.
Class 1 recalls are reserved for situations “in which there is a reasonable probability the the use of or exposure to a violative product will cause adverse consequences or death.”
In this most recent recall CareFusion/BD recalled 350,000 Alaris infusion pumps for faulty air detection sensors. The recall warns “interruption of infusion could lead to serious adverse health consequences or death.” Of greatest concern, the faulty sensors may cause the pump to stop therapy to the patients. Read More >
By: Gerard J. Myers, RT, CCP Emeritus, Eastern Perfusion International
Going back to the statement, that it would take a lot of air to cause you any harm makes you wonder how much air it would actually take to create a sudden, life threatening problem after the air went into the bloodstream. Read More >
By: Gerard J. Myers, RT, CCP Emeritus, Eastern Perfusion International
At birth, we are all born with an opening in the atrial wall of our heart that separates the right side of our heart and the left side of our heart. This opening is called a Foramen Ovale, and usually closes with our first few breaths at birth, sending venous blood to the lungs and arterial blood to the brain and the rest of the body. Read More >
By: Gerard J. Myers, RT, CCP Emeritus, Eastern Perfusion International
Part 1 of 3
When was the last time you, or one of your loved ones, was in a hospital bed with an intravenous line attached to your arm and a bag of intravenous fluid hanging from an IV pole beside you? Perhaps when the bag of fluid began to empty, a health care worker entered the room to hang another bag of the lifesaving liquid, or maybe just attach a smaller bag of medication to run into you intravenous line. Read More >
March 12 - 18 is Patient Safety Awareness Week, an initiative of the National Patient Safety Foundation that encourages everyone to Stand United for Patient Safety to reduce harm in patient care. #WEAREALLPATIENTS Read More >
Pumps are well known to have issues dealing with air in IV lines. Within the past 10 years, 2,549,871 pumps were included in recalls due to air-related accidents or incidents according to the FDA’s Maude database for adverse events. Read More >
The FDA just announced a recall of nearly 350,000 Alaris Syringe Pumps for faulty air detection sensors. Of great concern, the faulty sensors may cause the pump to stop therapy infusion to the patient. Healthcare professionals may have to clear the alarm and restart the infusion. The FDA recall warns that “interruption of infusion could lead to serious adverse health consequences or death.” Read More >